Outsourcing Pharma

MAY 9, 2024

A collaborative report released today (May 9) by Medicines Discovery Catapult (MDC), sheds light on the challenges facing the life sciences sector amidst recent economic turbulence.

86

86

STAT

APRIL 10, 2024

Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion, the companies announced Wednesday. It is the largest acquisition in Vertex’s history.

Immunization 133

Immunization 133

STAT

JANUARY 3, 2024

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

141

141

Pharmafile

MAY 1, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics have announced that they have entered into a collaborative partnership with the aim of ‘deliver[ing] robust and reliable automated liquid handling solutions that enable labs to streamline operations and generate consistent results’, according to the press release.

64

64

Outsourcing Pharma

MAY 15, 2024

Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at Ecolab Life Sciences to find out what the company is planning for the event and how it is navigating current challenges in the industry.

80

80

STAT

APRIL 25, 2024

Each year, STAT chooses a new class of Wunderkinds, showcasing stars of science and medicine who are in the midst of launching their careers. Editor’s note: A livestream of the event will be embedded below at 1 p.m.

82

82

STAT

MAY 9, 2024

Exact Sciences reported first-quarter revenues this week that beat market expectations, and the cancer detection company’s executives still believe they’re on track to meet expected 2024 revenue. That’s usually good news. Yet Exact shares are down nearly 11% on Thursday, dipping to $53.12

96

96

pharmaphorum

OCTOBER 17, 2023

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert Krystle Buntemeyer, CEO of SCORR Marketing, about the trends and changes for health sciences marketing over the past few years.

115

115

Pharmaceutical Technology

MAY 16, 2024

In this series, life sciences industry M&A veteran John Easton will discuss how digital deals differ from traditional life science deals

52

52

Outsourcing Pharma

MAY 1, 2024

We spoke with RenÃe about her journey from investment banking to science and the joy of bringing therapies to patients. RenÃe Aguiar-Lucander, CEO of Calliditas, is driving the advancement and launch of TARPEYO â the companyâs medication targeting rare disease IgA nephropathy.

86

86

ISPE

SEPTEMBER 28, 2023

Navigating Life Sciences Construction in California Trudy Patterson Thu, 09/28/2023 - 11:40 iSpeak Blog iSpeak Navigating Life Sciences Construction in California Gul Dusi 28 September 2023 Few industries have as deep a footprint in California, USA as life sciences. billion a year. billion a year. billion in 2019 to $17.3

Hospitals 98

Hospitals Documentation Pharmaceutical Companies Pharmaceutical Companies 98

STAT

MAY 7, 2024

Drug development is essentially a long, expensive bet: 90% of drugs fail during clinical trials, goes one of the life science industry’s most oft-quoted statistics.

Vaccines 96

Vaccines 96

pharmaphorum

JANUARY 25, 2024

Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.

112

112

Pharmafile

APRIL 11, 2024

Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share, totaling an approximate $4.9bn. Alpine’s lead […] The post Vertex to acquire Alpine Immune Sciences for $4.9bn appeared first on Pharmafile.

Immunization 59

Immunization 59

pharmaphorum

MARCH 18, 2024

Discover the top 7 challenges faced by pharmaceutical and life sciences companies in achieving patient-centricity and engaging healthcare professionals (HCPs). Explore strategies to overcome these obstacles for successful outreach efforts.

115

115

pharmaphorum

JANUARY 10, 2024

Explore the latest trends and projections in life sciences real estate, including the impact of digital health, the evolving needs of laboratory facilities, and the future of real estate in this sector. Stay ahead of the curve with insights into the industry's future.

113

113

pharmaphorum

NOVEMBER 16, 2023

Life sciences inspections and investigations Mike.Hammerton Thu, 16/11/2023 - 10:23 Bookmark this

113

113

European Pharmaceutical Review

MARCH 12, 2024

In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. Ensuring data integrity in the life science industry is crucial for regulatory compliance. What are three current key trends in data integrity?

Documentation 88

Documentation Data Entry Communication Compounding 88

Outsourcing Pharma

APRIL 23, 2024

At CPhI North America, Quotient Sciences is looking forward to reconnecting with its customers and giving them a preview of how we are looking to expand Translational Pharmaceutics further within the US.

69

69

Outsourcing Pharma

MAY 15, 2024

Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at EcoLab Life Sciences to find out what the pharmaceutical manufacturing firm is planning for the event and how it is navigating current challenges in the industry.

59

59

European Pharmaceutical Review

OCTOBER 10, 2023

Schneider Electric, a leader in digital transformation, energy management and automation, has announced the speaker lineup for its exclusive event, Life Sciences Innovation Day – Accelerating Digital Transformation Ambition. Registration begins at 9:00am. Event concludes at 4:30pm.

99

99

STAT

FEBRUARY 1, 2023

A recent study and accompanying news story in the preeminent journal Nature provocatively concludes that disruptive innovation in science has dramatically and mysteriously declined 90% since 1945. The study has prompted a wave of news coverage and tweets decrying the apparent languishing of modern science.

141

141

Pharmaceutical Technology

APRIL 22, 2024

GS-6212 is under clinical development by Gilead Sciences and currently in Phase I for Human Immunodeficiency Virus (HIV) Infections (AIDS).

98

98

pharmaphorum

DECEMBER 8, 2023

Life sciences industry predictions 2024: Curavit Mike.Hammerton Fri, 08/12/2023 - 14:15 Bookmark this

104

104

pharmaphorum

FEBRUARY 29, 2024

Explore the impact of the Inflation Reduction Act (IRA) on drug prices and negotiations within the life sciences industry, as it stands on the threshold of change. Gain insights into the potential outcomes and implications of this legislation.

102

102

STAT

NOVEMBER 1, 2023

Biotech and life sciences investors continue to draw in new funds even as the biotech stock indexes reach new lows. On Wednesday, VC firm Bioluminescence Ventures launched with $477 million to invest in biotech startups.

Pharmaceutical Companies 128

Pharmaceutical Companies Pharmaceutical Companies 128

Outsourcing Pharma

APRIL 16, 2024

Bios Health Group, a leading strategic and investment partner for life science companies and investors, has officially introduced the Bios Innovation Circle.

70

70

STAT

JUNE 6, 2023

Freshly minted life science Ph.D. graduates who have started families or have big loans, or are Black or female, say they plan to pursue postdoc positions at lower rates than their peers, according to a STAT analysis that includes previously unreported data from the National Center for Science and Engineering Statistics.

121

121

pharmaphorum

SEPTEMBER 15, 2023

Driving data & analytics transformation in life sciences Mike.Hammerton Fri, 15/09/2023 - 08:00 Bookmark this

121

121

pharmaphorum

MARCH 5, 2024

Explore how innovation is shaping the future of life sciences through digital transformation and AI. Learn how incorporating cutting-edge technologies can drive success in the industry.

78

78

Outsourcing Pharma

APRIL 24, 2024

From a child's chemistry set given to her by her grandfather to watching Open University maths programs, Karen Ooms seemed destined for a career in science.

100

100

pharmaphorum

DECEMBER 8, 2022

Life Sciences Council. Do you know about the Life Sciences Council (LSC)? The LSC has a website on Gov.uk, but the page says Life Sciences Council. A post from the director of health and life sciences at Innovate UK, Richard J Hebdon, also bigged up the news before the Council met about four health missions.

Documentation 100

Documentation 100

STAT

OCTOBER 17, 2023

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

FDA 128

FDA 128

Pharmaceutical Technology

FEBRUARY 7, 2024

Gilead Sciences has announced a 22.9% increase in net income of $5.61bn for FY23 as against $4.56bn in FY22.

98

98

Drug Store News

SEPTEMBER 13, 2023

Lucas Morgan, partner at Frier Levitt’s Healthcare and Life Sciences Litigation Department, shares important information pharmacists need to know to protect their businesses.

118

118

STAT

OCTOBER 19, 2023

Their philanthropic funding group, the Chan Zuckerberg Initiative, is committed to investing in an array of fields, including science, education, housing insecurity, and expanding access to startup capital to entrepreneurs of color.

Compounding 133

Compounding 133

STAT

MARCH 4, 2024

Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

88

88